Results 51 to 60 of about 5,044 (130)

Cyclic pyrrole-imidazole polyamides targeted to the androgen response element [PDF]

open access: yes, 2009
Hairpin pyrrole−imidazole (Py-Im) polyamides are a class of cell-permeable DNA-binding small molecules that can disrupt transcription factor−DNA binding and regulate endogenous gene expression.
Chenoweth, David M.   +4 more
core   +2 more sources

Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans

open access: yesPharmacology Research &Perspectives, Volume 12, Issue 5, October 2024.
Proposed biotransformation pathways of aficamten in male humans. Abstract Aficamten, a cardiac myosin inhibitor, is being developed for the treatment of patients with symptomatic hypertrophic cardiomyopathy (HCM). The purpose of this study was to determine the absorption, metabolism, and excretion of aficamten.
Donghong Xu   +6 more
wiley   +1 more source

Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese [PDF]

open access: yes, 2014
BACKGROUND: Cytochrome P450 (CYP) 2C19 is a very important drug metabolizing enzyme. Although the single nucleotide polymorphisms (SNPs) of CYP2C19 G681A and G636A have been suggested that they may increase the incidence of cardiovascular events, the ...
Dongliang Wang   +6 more
core   +2 more sources

Pharmacogenetics in Type 2 Diabetes: Potential Implications for Clinical Practice [PDF]

open access: yes, 2013
Pharmacogenetic research aims to study how genetic variation may influence drug efficacy and/or toxicity; pharmacogenomics expands this quest to the entire genome. Pharmacogenetic findings may help to uncover new drug targets, illuminate pathophysiology,
Florez, Jose Carlos, Huang, Chunmei
core   +1 more source

Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition [PDF]

open access: yes, 2016
Efavirenz pharmacokinetics is characterized by large between-subject variability, which determines both therapeutic response and adverse effects.
Bies, Robert R.   +6 more
core   +1 more source

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents [PDF]

open access: yes, 2012
Background: Dose banding is a recently suggested dosing method that uses predefined ranges (bands) of body surface area (BSA) to calculate each patients dose by using a single BSA-value per band.
Baker, S.D. (Sharyn)   +5 more
core   +1 more source

Inhibition of cytochrome P450 activities by extracts of 'Hyptis verticillata' Jacq. : assessment for potential HERB-drug interactions [PDF]

open access: yes, 2018
Understanding the potential for adverse drug reactions (ADRs), from herb-drug interactions, is a key aspect of medicinal plant safety, with particular relevance for public health in countries where medicinal plant use is highly prevalent. We undertook an
Barker, James   +6 more
core   +2 more sources

Individualization of Immunosuppressive Therapy after Solid Organ Transplantation [PDF]

open access: yes, 2014
__Abstract__ When an individual’s kidneys fail, there are three treatment options: hemodialysis, peritoneal dialysis or kidney transplantation. A successful kidney transplantation results in the best patient survival and a better quality of life ...
Bouamar, R. (Rachida)
core   +1 more source

Interaktionen kardialer und antiretroviraler Medikation [PDF]

open access: yes, 2018
Zusammenfassung: Neue therapeutische Optionen der hochaktiven antiretroviralen Therapie (HAART) haben die Morbidität und Mortalität von HIV-infizierten Patienten deutlich gesenkt, so dass nun vermehrt die altersspezifischen Erkrankungen manifest werden ...
Drewe, Jürgen, Egger, Sabin
core  

Enantiomers of methylenedioxy designer drugs : the role of cytochrome P450s and catechol-O-methyltransferase in their metabolism [PDF]

open access: yes, 2009
In the presented studies, the CYP dependent, enantioselective N-dealkylation and demethylenation of the designer drugs MDMA (Ecstasy), MBDB (Eden), and MDEA (Eve) was investigated.
Meyer, Markus Robert
core  

Home - About - Disclaimer - Privacy